Shining a Light on HER2-Low and HER2-Ultralow Metastatic Breast Cancer: A Pathologist’s Guide to Bridging the Diagnostic Gaps

Content Format:

Slideset

Credit Type:

--

Credits:

--
Risk Factors for Recurrence, Molecular Testing, and Treatment of Patients With HR-Positive/HER2-Negative EBC

Content Format:

Text Module

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.50
Risk Factors for Recurrence, Molecular Testing, and Treatment of Patients With HR-Positive/HER2-Negative EBC

Content Format:

Slideset

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.50
Integration of Novel Antibody–Drug Conjugates in Advanced HER2-Low, Hormone Receptor–Positive, and Triple-Negative Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
InterACT Oncology Team Training: Improving Clinical Outcomes for Patients With High-Risk HR-Positive/HER2-Negative Early-Stage Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.75
Sequencing Treatment in HER2-Positive Metastatic Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Pushing the Boundaries of Unresectable or Metastatic HER2-Low Breast Cancer Treatment: New Insights and Innovations

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Pushing the Boundaries of Unresectable or Metastatic HER2-Low Breast Cancer Treatment: New Insights and Innovations

Content Format:

Slideset

Credit Type:

--

Credits:

--
Advances in CDK4/6 Inhibition in EBC: Expert Guidance and Case Challenges for the Multidisciplinary Team

Content Format:

Slideset

Credit Type:

--

Credits:

--
Spectrum of HER2 Expression and Its Clinical Implications in Breast Cancer

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.50
HER2 Expression in Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
How I Manage Key Toxicities With Adjuvant CDK4/6 Inhibitors for Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Studies in Breast Cancer: Independent Conference Coverage of the 2023 ASCO Annual Meeting

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Conference to Clinic: Expert Analysis of the Top Breast Cancer Abstracts From the 2023 Oncology Meeting in Chicago

Content Format:

Video

Credit Type:

AMA

Credits:

0.50
Conference to Clinic: Breast Cancer

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
An Expert’s Guide to ASCO 2023: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Individualizing Care for Patients With Triple-Negative Breast Cancer

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Podcast PearlsIndividualizing Care for Patients With Triple-Negative Breast Cancer

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Smarter. Stronger. Together: Optimizing Personalized Triple-Negative Breast Cancer Care for Providers and Patients

Content Format:

Multimedia

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Treating Brain Metastases in HER2-Positive Breast Cancer: Progress at Last!

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Smarter. Stronger. Together: Optimizing Personalized Triple-Negative Breast Cancer Care for Providers and Patients

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Key Studies in Breast, Gynecologic, Renal Cell, Urothelial, Lung, Hepatobiliary, and Skin Cancers: CCO Independent Conference Highlights of the 2022 ESMO Congress

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.25
An Expert’s Guide to ESMO 2022: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Optimal Utilization of Ki67 Testing in HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Oncology and Pathology Healthcare Teams

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Optimal Utilization of Ki67 Testing in HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Oncology and Pathology Healthcare Teams

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Highlights From the 2021 SABCS Symposium

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
A Look Ahead to SABCS 2021

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Podcast Pearls

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Expert Answers to Clinician Questions

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Individualizing Therapeutic Decisions to Improve Patient Outcomes

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
ExpressPointsCDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Individualizing Therapeutic Decisions to Improve Patient Outcomes

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Clinical Decision-Making for Patients With HR+ HER2- Early Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Update: Debating Optimal Neoadjuvant Therapy and Future Considerations on the Horizon for HR+/HER2- EBC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
ExpressPoints:Clinical Decision-Making for Patients With HR+ HER2- Early Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Adjuvant Therapy for Patients With HR+/HER2- EBC at High Risk of Recurrence

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Debating Optimal Neoadjuvant Therapy and Future Considerations on the Horizon for HR+/HER2- EBC: Downloadable Slides

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
ExpressPoints: HER2-Positive Breast Cancer: A Guide Through an Evolving Treatment Landscape

Content Format:

Slideset

Credit Type:

--

Credits:

--
Managing Patients With HER2+ Breast Cancer and Brain Metastasis: Slides

Content Format:

Slideset

Credit Type:

--

Credits:

--
HER2 Testing and Treatment Decisions In Breast Cancer: Slides

Content Format:

Slideset

Credit Type:

--

Credits:

--
New Targeted Therapies for HER2-Positive Metastatic Breast Cancer: Downloadable Slides

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Insights Into Sequencing Treatment and Overcoming Resistance in HR-Positive/HER2-Negative ABC

Content Format:

Video

Credit Type:

AMA

Credits:

1.25
ExpressPoints: Sequencing Treatment and Overcoming Resistance in HR-Positive/HER2-Negative ABC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
PI3K/AKT/mTOR Inhibitors and Future Directions in HR+/HER2- Advanced Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Key Updates in the Treatment of HER2-Positive Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
New Insights in Breast Cancer: Independent Conference Coverage of SABCS 2019

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
New Developments in Chemotherapy-Based Treatment for Breast Cancer: Insights From SABCS 2019

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
A Look Ahead to the 2019 SABCS Meeting

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

0.25